– Ajaz Hussain, Management Consultant
Poor data integrity practices noted by US FDA & UK’s MHRA at several companies in India
• Remediation poses several challenges. How to understand why?
It has been alleged that “Chalta-Hai” attitude etc., are part of the cause…
• Understanding human behavior is critical. What may be the root cause of noted ‘cluster’ of challenges?
Both US and UK regulators have acknowledged that many companies in India state-of-the art
• Reason for optimism. It is already happening.
Authorities in India have expressed displeasure on the notion of dual standards
• Signal standard will take time. How to move in this direction and create a win-win opportunity?
Please see the complete presentation @ http://www.slideshare.net/a2zpharmsci/data-
integritytime-to-integrate-human-factros
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…